Loading...

SOHO 2026 Annual Meeting

This website and third-party tools we use rely on cookies for the best user experience. By selecting "I agree", you agree to cookie usage as described in our Privacy Policy.

1,267 posters, 47 videos, 13 topics, 4 sessions, 853 authors

ePostersLive by SciGen Technologies S.A. All rights reserved.

SOHO 2026 Annual Meeting

September 9 - 12, 2026 | George R. Brown Convention Center, Houston, Texas

Home Posters by Code Posters by Title Authors Affiliations Topics Sessions Videos Audios Previous meetings

Posters by Title

Type your Poster Title, then hit apply

Showing 1,267 results.

Thumbnail for Transfer-Pathway Vulnerability, Not Final Hospital Type, Defines Early Mortality Risk in Acute Promyelocytic Leukemia: National NIS/NRD Data, 2016-2022

AML - 252

Transfer-Pathway Vulnerability, Not Final Hospital Type, Defines Early Mortality Risk in Acute Promyelocytic Leukemia: National NIS/NRD Data, 2016-2022

Woo Joo Lee

Poster Presenter: Woo Joo Lee

Thumbnail for Transformation of Multiple Myeloma Survival in the Novel Therapy Era: From a Once Rapidly Fatal Disease to a Chronic Malignancy

MM - 841

Transformation of Multiple Myeloma Survival in the Novel Therapy Era: From a Once Rapidly Fatal Disease to a Chronic Malignancy

Damilola Ologbe

Poster Presenter: Damilola Ologbe

Previous 1...127 128 129 130 131 132 133...141 Next

Copyright © 2015-2026, ePostersLive® SciGen is a registered trademark of SciGen Technologies S.A. Patent pending.

Thumbnail for Transfusion Patterns and Clinical Characteristics According to Treatment Strategy in Acute Myeloid Leukemia: A 5-Year Experience at a National Referral Oncology Center in Mexico

AML - 1536

Transfusion Patterns and Clinical Characteristics According to Treatment Strategy in Acute Myeloid Leukemia: A 5-Year Experience at a National Referral Oncology Center in Mexico

Janeth Araujo Cardenas

Poster Presenter: Janeth Araujo Cardenas

Thumbnail for Transplant Outcomes and Rates of Graft-Versus-Host Disease for FLT3-ITD Acute Myeloid Leukemia by Graft Source in the Era of Posttransplant Gilteritinib Maintenance

AML - 1029

Transplant Outcomes and Rates of Graft-Versus-Host Disease for FLT3-ITD Acute Myeloid Leukemia by Graft Source in the Era of Posttransplant Gilteritinib Maintenance

Joseph Mort

Poster Presenter: Joseph Mort

Thumbnail for Treatment Burden Among Patients Aged 75 Years or Older With Chronic Lymphocytic Leukemia and Small Lymphocytic Lymphoma (CLL/SLL)

CLL - 991

Treatment Burden Among Patients Aged 75 Years or Older With Chronic Lymphocytic Leukemia and Small Lymphocytic Lymphoma (CLL/SLL)

Daniel A. Ermann

Poster Presenter: Daniel A. Ermann

$Thumbnail for Treatment Discontinuation and Dose Modifications Associated With Bispecific Antibody Therapy in Relapsed/Refractory Multiple Myeloma: A Systematic Review and Meta-Analysis$

MM - 079

Treatment Discontinuation and Dose Modifications Associated With Bispecific Antibody Therapy in Relapsed/Refractory Multiple Myeloma: A Systematic Review and Meta-Analysis

Rithika Manjunatha Reddy

Poster Presenter: Rithika Manjunatha Reddy

Thumbnail for Treatment Intensity Does Not Improve Survival in TP53-Mutated Acute Myeloid Leukemia: Real-World Outcomes From a Racially Diverse Academic Center

AML - 897

Treatment Intensity Does Not Improve Survival in TP53-Mutated Acute Myeloid Leukemia: Real-World Outcomes From a Racially Diverse Academic Center

Eiline Cai

Poster Presenter: Eiline Cai

Thumbnail for Treatment Intensity Rather Than Isoform Is Associated With Improved Outcomes in IDH Mutated AML: A Single-Center Cohort Study

AML - 1113

Treatment Intensity Rather Than Isoform Is Associated With Improved Outcomes in IDH Mutated AML: A Single-Center Cohort Study

Ashlyn O'Leary

Poster Presenter: Ashlyn O'Leary

$Thumbnail for Treatment Landscape of Relapsed/Refractory CLL in Low-Resource Countries$

CLL - 239

Treatment Landscape of Relapsed/Refractory CLL in Low-Resource Countries

Muhammad Usman

Poster Presenter: Muhammad Usman

ePosters in

Topics Sessions

Acute Lymphoblastic Leukemia (ALL)(71)Acute Myeloid Leukemia (AML)(230)Aggressive B-Cell Lymphoma (ABCL)(114)Cellular Therapy (CT)(128)Chronic Lymphocytic Leukemia (CLL)(110)Chronic Myeloid Leukemia (CML)(55)Hodgkin Lymphoma (HL)(54)Indolent B-Cell Lymphoma (IBCL)(47)Mantle Cell Lymphoma (MCL)(23)Multiple Myeloma (MM)(234)

Previous 1 2 Next

Sponsors